Don Healey - 24 Jan 2025 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Reporting relationship: Chief Technology Officer
Issuer ticker: ACET
Reported as of: 24 Jan 2025
Net transaction value: -$7,891
SEC form: 4
Accepted by SEC: 28 Jan 2025, 16:28:10 UTC
Prior SEC filing: 07 Jun 2024
Next SEC filing: 04 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Nick Harvey, Attorney-in-Fact

Key filing fact

Don Healey filed Form 4 for Adicet Bio, Inc. (ACET) on 28 Jan 2025.

Key facts

This page summarizes Don Healey's Form 4 filing for Adicet Bio, Inc. (ACET).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Jan 2025, 16:28.

Change

Previous filing in this sequence was filed on 07 Jun 2024.
Current net transaction value: -$7,891.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACET transaction

Common Stock

Tax liability

Transaction value: $7,891
Shares: -8,560
Change %: -12%
Price: $0.9218
Shares after: 63,769
Date: 24 Jan 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.